# A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations

> **NCT03726827** · — · COMPLETED · sponsor: **Fatty liver Foundation** · enrollment: 1006 (actual)

## Conditions studied

- NAFLD
- NASH - Nonalcoholic Steatohepatitis
- Cirrhosis, Liver
- Fatty Liver

## Interventions

- **OTHER:** Fibroscan screening

## Key facts

- **NCT ID:** NCT03726827
- **Lead sponsor:** Fatty liver Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-01
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-08-31
- **Target enrollment:** 1006 (ACTUAL)
- **Last updated:** 2019-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03726827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03726827, "A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03726827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*